DCW Ltd

- Current repayment of Rs. 125 crores in debt is being serviced entirely from internal cash generation; no new borrowing for this repayment (Page 14). - Short-term borrowing is around Rs. 25-26 crores, and there is a rotational short-term funded borrowing of Rs. 330-340 crores included in creditors (Page 14). - Long-term debt has reduced by Rs. 100 crores to Rs. 409 crores; cash on books is Rs. 170 crores, resulting in net debt of about Rs. 280 crores (Page 13 & 5). - Routine maintenance CAPEX of Rs. 35-40 crores will be funded from internal accruals; however, growth CAPEX will be funded through bank borrowings (Page 12). - No indication of raising equity or fresh fundraising through equity at present (throughout transcript). - Discussions are ongoing for growth CAPEX, and an announcement is expected soon, which may involve further bank borrowings but not explicit equity raising (Page 12).

- Routine CAPEX: Rs. 35 to Rs. 40 crores per annum funded from internal accruals. - Efficiency CAPEX: Rs. 15 to Rs. 20 crores for operational improvements. - Growth CAPEX: To be funded through bank borrowings; final plans to be announced soon. - Focus on making South facility chlorine neutral with additional CAPEX over next 1 to 1.5 years; aims to balance chlorine usage and add value-added products. - Potential future diversification into new chemistries is under discussion but premature to share details. - Completed major payment of Rs. 125 crores for growth projects in CPVC and SIOP. - Invested Rs. 20 crores in group Captive Solar project; financial benefits expected from H2 FY25. - Capacity expansions underway: CPVC capacity increased to 20,000 tons per annum; SIOP capacity to increase from 18,000 to 27,000-28,000 tons post debottlenecking.

- CPVC capacity expanded to 20,000 tons per annum with plans to operate at full capacity and increase sales. - SIOP production capacity to be increased from 18,000 tons to around 27,000-28,000 tons after debottlenecking; targeting sales of 25,000-26,000 tons in FY25. - Specialty Chemical segment expected to drive growth with higher volume focus despite volatile pricing; goal to increase specialty EBITDA contribution beyond 50%. - For FY25, the company aims to leverage capacity additions in CPVC and SIOP to grow volumes substantially, compensating for price pressures. - Plans to improve margins and sales stability through value-added products and operational efficiencies. - Demand across products except Caustic Soda is considered reasonably strong with opportunities in both domestic and international markets.

- DCW aims to increase Specialty Chemicals EBITDA to over 50% of total EBITDA, providing bottom-line stability. - Growth capex is planned to expand capacity in CPVC (from 12,000 to 20,000 tons per annum) and SIOP (from 18,000 to ~27,000-28,000 tons), expecting to fill increased capacity by FY25. - Specialty segments (SIOP, CPVC, Synthetic Rutile) are targeted as key profit contributors with elevated margins compared to commodities. - Commodity segments like Caustic Soda continue under pressure with limited profitability; focus remains on value-added products. - Management foresees revenue growth driven by volume increases in Specialty chemicals rather than price hikes due to volatile market prices. - CAPEX for growth will be partly funded by bank borrowings; routine maintenance CAPEX funded from internal accruals. - Earnings growth expected to improve in H2 FY25 as recent capacity additions stabilize and market demand picks up.

- The transcript does not explicitly mention the current or expected order book or specific pending orders for DCW Limited. - However, management highlights strong demand in Specialty Chemicals, particularly in CPVC and SIOP, with plans to increase capacity and sales volumes. - SIOP sales target for FY25 is around 25,000 to 26,000 tons, up from approximately 20,000 tons sold in FY24. - CPVC production capacity has been expanded to 20,000 tons per annum with full utilization expected. - Synthetic Rutile is operating at around 90% capacity with good export demand. - The company is optimistic about filling increased capacity in SIOP within a year to year and a half, indicating a healthy order inflow. - Focus is on volume growth and expanding domestic and international markets, though no explicit order backlog numbers are provided.